Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin

Journal of Thoracic and Cardiovascular Surgery

Volumn 118, Issue 5, 1999, Pages 908-915

  Nguyen, D M ^a   Chen, A ^a   Mixon, A ^a   Schrump, D S ^a   Roth, J A ^a   Ferguson, M K ^a   Rusch, V W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; ANSAMYCIN DERIVATIVE; BENZOQUINONE DERIVATIVE; GENE PRODUCT; ONCOPROTEIN; PACLITAXEL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032753492     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70061-9     Document Type: Article

References (27)

1. T Akiyama C Sudo H Ogawara K Toyoshima T Yamamot The product of the human c- erb -b2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity Science 232 1986 1644 1646
2. MA Alaoui-Jamali J Paterson AE Al Moustafa L Yen The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications Biochem Cell Biol 75 1997 315 325
3. CM Tsai KT Chang LH Wu JY Chen AF Gazdar T Mitsudomi Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non–small cell lung cancer cell lines Cancer Res 56 1996 206 209
4. CM Tsai D Yu KT Chang LH Wu RP Perng NK Ibrahim Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells J Natl Cancer Inst 87 1995 682 684
5. D Yu B Liu M Tan J Li SS Wang MC Hung Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms Oncogene 13 1996 1359 1365
6. XL You L Yen N Zeng-Rong AE Al Moustafa MA Alaoui-Jamali Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells Oncogene 17 1998 3177 3186
7. DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
8. M Diez M Pollán M Maestro A Torres D Ortega A Gómez Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue Br J Cancer 75 1997 684 689
9. CC Hsieh KC Chow HJ Fahn CM Tsai WY Li MH Huang Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung Ann Thorac Surg 66 1998 1159 1163
10. JG Supko RL Hickman MR Grever L Malspeis Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent Cancer Chemother Pharmacol 36 1995 305 315
11. WG An RC Schnur L Neckers MV Blagosklonny Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity Cancer Chemother Pharmacol 40 1997 60 64
12. TW Schulte L Neckers The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin Cancer Chemother Pharmacol 42 1998 273 279
13. C Chavany E Mimnaugh P Miller R Bitton P Nguyen J Trepel p185erbB2 binds to GRP94 in vivo: dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2 J Biol Chem 271 1996 4974 4977
14. EG Mimnaugh C Chavany L Neckers Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin J Biol Chem 271 1996 22796 22801
15. P Miller C DiOrio M Moyer RC Schnur A Bruskin W Cullen Depletion of the erb B-2 gene product p185 by benzoquinoid ansamycins Cancer Res 54 1994 2724 2730
16. A Krishan Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining J Cell Biol 66 1975 188 193
17. KL Donaldson GL Goolsby AF Wahl Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle Int J Cancer 57 1994 847 855
18. J Fueyo C Gomez-Manzano VK Puduvalli P Martin-Duque R Perez-Soler VA Levin Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy Int J Oncol 12 1998 665 669
19. AM Petit J Rak MC Hung P Rockwell N Goldstein B Fendly Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors Am J Pathol 151 1997 1523 1530
20. D Yu SS Wang KM Dulski CM Tsai GL Nicolson MC Hung c- erb B-2 /neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties Cancer Res 54 1994 3260 3266
21. J Baselga L Norton J Albanell YM Kim J Mendelsohn Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts Cancer Res 58 1998 2825 2831
22. MN Barnes JS Deshane GP Siegal RD Alvarez DT Curiel Novel gene therapy strategy to accomplish growth factor modulation induces enhanced tumor cell chemosensitivity Clin Cancer Res 2 1996 1089 1095
23. NT Ueno D Yu MC Hung Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A Oncogene 15 1997 953 960
24. SL Lai LJ Goldstein MM Gottesman I Pastan CM Tsai BE Johnson MDR1 gene expression in lung cancer J Natl Cancer Inst 81 1989 1144 1150
25. D Yu T Jing B Liu J Yao M Tan TJ McDonnell Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase Mol Cell 2 1998 581 591
26. JL Eiserman DL Sentz EG Zuhowski TS Ramsland Plasma pharmacokinetics and tissue distribution of 17-allylaminogeldanamycin (NSC330507), a prodrug for geldanamycin, in CD2F1 mice and Fisher 344 rats [abstract] Proc AACR 38 1997 308
27. J Page J Heath R Fulton E Yalkowsky Comparison of geldanamycin (NSC122750) and 17-allylaminogeldanamycin (NSC330507D) toxicity in rats [abstract] Proc AACR 38 1997 308